Therapeutic Antibodies

#Artificial intelligence (AI) #Cancer research #Immunotherpy #Oncology #Radiopharmaceuticals #Therapeutic Antibodies

What lies ahead in cancer research?

Megan Thomas comments and speaks with experts to uncover the future of cancer research. Artificial intelligence (AI) It’s not whether AI should be used, it’s when and how. Until several hurdles are overcome, such as data quality, data privacy and security, as well as regulatory and ethical challenges, this is… Read More

#Cancer Research #Exclusive Content

Antibodies
#Immunotherapy #Interview #Monoclonal antibodies #Oncology #Therapeutic Antibodies

The new wave: Creating next-gen antibody therapies

Diana Spencer speaks to Dr Wansu Qiu, Technical Account Manager at Sino Biological US, about how advances in engineering technologies are paving the way for improved antibody drugs. DS: Since 1986, the FDA has granted marketing authorisation to over 100 therapeutic antibodies, many in oncology. Why has this been a… Read More

#Exclusive Content #Opinion

Therapeutic antibodies
#IsomAb #Pfizer #Therapeutic Antibodies

Pfizer supports antibody for peripheral arterial disease

UK-based biotechnology company IsomAb has announced the nomination of a development candidate for peripheral arterial disease (PAD), therapeutic antibody ISM-001. ISM-001 is designed to neutralise VEGF-A165b, the anti-angiogenic VEGF-A splice isoform which acts as a brake on development of new blood vessels leading to chronic limb… Read More

#News

#Therapeutic Antibodies

Infographic: Optimize Your mAb Manufacturing with Proven Analytical Strategies

Key takeaways: Boost Workflow Efficiency: Discover how end-to-end testing can enhance the efficiency of your monoclonal antibody production process. Ensure Compliance: Learn about the importance of accurate and precise testing at various production stages to meet or exceed regulatory guidelines. Guarantee Quality: Understand how proper testing ensures product safety, quality, and potency throughout… Read More

#Infographics

#Drug discovery #Therapeutic Antibodies

Webinar: Next-gen antibody discovery: Leveraging DNA immunisation and single B-cell cloning for high-affinity & specificity rabbit mAbs – FUJIFILM – 09.09.2024 DDW

Watch this engaging and informative webinar on Fujifilm Wako’s groundbreaking advancements in rabbit monoclonal antibody discovery. Traditional hybridoma technology has long struggled with inefficiencies, especially in producing rabbit monoclonal antibodies. Fujifilm Wako has surmounted these challenges by integrating DNA immunisation with its proprietary single B-cell cloning technique, paving the way… Read More

#Webinars

Therapeutic antibodies
#Antibody drug conjugate (ADC) #Bispecific Antibodies #Drug discovery #eBook #Therapeutic Antibodies

eBook: The impact of therapeutic antibody discovery

A new eBook, sponsored by Sino Biological, is now available for download entitled ‘The impact of therapeutic antibody discovery’. The first monoclonal antibody (mAb), Orthoclone, was approved in 1986 to help prevent rejection in organ transplantation. Since then, the US Food and Drug… Read More

#News

The impact of therapeutic antibody discovery
#Antibody drug conjugate (ADC) #Bispecific Antibodies #Drug discovery #eBook #Therapeutic Antibodies

The impact of therapeutic antibody discovery

This eBook explores the challenges and opportunities in the therapeutic antibody market, the range of applications for these therapies and the move towards more targeted and effective next-generation antibody treatments. Download this exclusive eBook to learn more about: How artificial intelligence and machine learning are benefitting antibody discovery and design… Read More

#DDW eBooks #Intelligence

#Therapeutic Antibodies

eBook: The impact of therapeutic antibody discovery

This eBook sponsored by Sino Biological explores the challenges and opportunities in the therapeutic antibody market, the range of applications for these therapies and the move towards more targeted and effective next-generation antibody treatments. Download this exclusive eBook to learn more about:   How artificial intelligence and machine learning are… Read More

#DDW eBooks

Molecular,Model,Of,Antibody
#Drug discovery #Monoclonal antibodies #Therapeutic Antibodies #Webinar

Where is the opportunity in the therapeutic antibody market?

In this webinar, you will hear from Dr Jill O’Donnell-Tormey, CEO and Director of Scientific Affairs at Cancer Research Institute; Dr Sheila Keating, VP of Immunology at Gigagen; as well as event sponsors Dr Milind Nigam, Leader – Scientific Solutions Consulting at Benchling, and Dr… Read More

Webinar date:
Brought to you by Benchling & Bio-Rad
#Webinars

Child receiving treatment for malaria
#Africa #Clinical trial #Malaria #Monoclonal antibodies #Therapeutic Antibodies

Experimental malaria monoclonal antibody prevents infection

A single injection of an experimental monoclonal antibody called L9LS was 77% effective at preventing malaria infection in children in Mali, according to the results of a mid-stage clinical trial. L9LS binds to and neutralises ‘sporozoites’, the form of the malaria parasite transmitted by mosquitoes that… Read More

#News #Trending News

#Antibodies #Artificial intelligence (AI) #Monoclonal antibodies #Therapeutic Antibodies

Therapeutic antibody potential in 2024

DDW’s Megan Thomas speaks to industry experts and thought leaders about the potential for therapeutic antibodies in 2024. Many of the best-selling drugs in 2023 were monoclonal antibody (mAB) therapies, including Keytruda (pembrolizumab), Humira (adalimumab), and Dupixent (dupilumab)1. This won’t come as a surprise when you… Read More

#Exclusive Content

Monoclonal antibody
#Antibodies #Drug discovery #eBook #Monoclonal antibodies #Therapeutic Antibodies

eBook: Drug discovery and the impact of mAbs

The low toxicity and high specificity of monoclonal antibodies (mAbs) continue to make them an appealing target for clinical research and investment. During 2023, 16 antibody therapeutics were granted approvals in the US or EU, either for the first time or for a new indication, covering uses as… Read More

#News

Monoclonal antibodies eBook cover
#Antibodies #Drug discovery #eBook #Monoclonal antibodies #Therapeutic Antibodies

Drug discovery and the impact of mAbs

This eBook, sponsored by Thermo Fisher Scientific, explores the impact of monoclonal antibodies (mAbs) on the treatment of cancer, autoimmune and infectious diseases, and inflammatory conditions, as well as the latest clinical research and where the innovation in mAb development might be in the future. Download this exclusive eBook to… Read More

#DDW eBooks #Intelligence